M 575 (Modafinil 200 mg)
Pill imprint M 575 has been identified as Modafinil 200 mg.
Modafinil is used in the treatment of chronic fatigue syndrome; adhd; shift work sleep disorder; narcolepsy; obstructive sleep apnea/hypopnea syndrome (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Modafinil 200 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M 575
- Strength:
- 200 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-5575
- Inactive Ingredients:
- croscarmellose sodium
calcium phosphate dibasic anhydrous
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0562 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More about modafinil
Consumer resources
- Other brands: Provigil
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
